Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aspen AerogelsASPN +0.64%67 Days Payable is 33.86 as of Jun. 2026, which is 27% below its 10-year median of 46.23. GuruFocus rates ASPN with a GF Score™ of 67/100 and a GF Value™ of $4.81 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,556 Chemicals companies, Aspen Aerogels ranks worse than 75% on this metric.
The historical rank and industry rank for Aspen Aerogels's Days Payable or its related term are showing as below:
ASPN'
s Days Payable Range Over the Past 10 Years
Min: 34.86 Med: 46.23 Max: 106.23
Current: 34.86
During the past 13 years, Aspen Aerogels's highest Days Payable was 106.23. The lowest was 34.86. And the median was 46.23.
ASPN's Days Payable is ranked worse than 75% of 1556
companies
in the Chemicals industry
Industry Median: 60.12
vs ASPN: 34.86
Aspen Aerogels's Days Payable
declined
from Jun. 2025 (57.94) to Jun. 2026 (33.86).
It may suggest that Aspen Aerogelsaccelerated paying its suppliers.
The historical data trend for Aspen Aerogels's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Aspen Aerogels's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspen Aerogels Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Aspen Aerogels's Days Payable distribution charts can be found below:
* The bar in red indicates where Aspen Aerogels's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Aspen Aerogels's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspen Aerogels (ASPN) has a Days Payable of 33.86 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aspen Aerogels and its competitors. This is 27% below median its historical median of 46.23. Over the past decade, Aspen Aerogels' Days Payable has ranged from 34.86 to 106.23. According to the industry distribution chart, Aspen Aerogels ranks #1167 out of 1556 companies in the Chemicals industry, placing it in the top 75%.
Is Aspen Aerogels' Days Payable too high?
Aspen Aerogels' current Days Payable of 33.86 is 27% below median its 10-year median of 46.23. Over the past 10 years, this metric has ranged from a low of 34.86 to a high of 106.23. The Chemicals industry median Days Payable is 60.12. Aspen Aerogels' value of 33.86 is 43.7% below this industry median. Based on the distribution chart, Aspen Aerogels ranks #1167 out of 1556 companies in the Chemicals industry, which is below the industry midpoint. Overall, Aspen Aerogels has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Aerogels' Days Payable compare to AIRJ and PPIH?
According to the Chemicals industry distribution chart, Aspen Aerogels ranks #1167 out of 1556 companies for Days Payable. This places Aspen Aerogels in the lower half of its industry. The industry median Days Payable is 60.12. Aspen Aerogels' value of 33.86 is 43.7% below this benchmark. Historically, Aspen Aerogels' own Days Payable has ranged from 34.86 to 106.23 over the past decade. While the company's 10-year median is 46.23 vs. the industry median of 60.12, Aspen Aerogels has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 60.12, based on 1,556 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aspen Aerogels's current Days Payable of 33.86 is 43.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aspen Aerogels and its competitors. For the Chemicals industry, the median Days Payable is 60.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aspen Aerogels's current Days Payable is 33.86, which is 27% below median its own 10-year median of 46.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Aerogels stock overvalued right now?
Based on GuruFocus' analysis, Aspen Aerogels (ASPN) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.81, compared to a current price of $6.29 — trading 30.8% above its estimated fair value. The current Days Payable is 33.86, which is 27% below median its 10-year median of 46.23 and 43.7% below the Chemicals industry median of 60.12. Aspen Aerogels' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Aspen Aerogels (ASPN), the current Days Payable is 33.86 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aspen Aerogels (ASPN) Overvalued in 2026?
Based on GuruFocus' analysis, Aspen Aerogels stock appears to be overvalued.
The current stock price of $6.29 is trading 30.8% above its estimated GF Value™ of $4.81.
GuruFocus considers Aspen Aerogels to be Significantly Overvalued.
Key valuation signals for ASPN:
Days Payable: 33.86 (27% below median its 10-year median of 46.23)
GF Value™: $4.81 vs. price of $6.29 (30.8% above fair value)
Industry Position: 43.7% below the Chemicals median (#1167 of 1556)
No single metric tells the full story. See the ASPN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
67GF Score
Get the complete analysis for ASPN
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASPN has been successfully added to your 
